Member Info for ontarget

Are you valuing the cash raised at 0?

They're very obviously collecting shares this morning - expect a large buy order to show later.

"The next company announcement isn't due until mid December."

How would you know that Kingalf?

Has anyone tried to get in contact with the new CEO?

You think the £1.7m raised less than 3 months ago will have run out already testpack? If so, what do you think it's been spent on?

Can't disagree there. Hopefully the new CEO is the communicative type and maybe after a week in his new job he'll give us a nice update next week?

Are you concluding there is lack of urgency because there's been no update, or do you have other information?
I didn't expect them to report on the progress of every patient because no valid scientific conclusions can be drawn from that - hence the 300 participants. I would't have thought they need to treat the full 300 before inferring anything of interest though.

This stock is well under the radar with very little in terms of communication over the last 3-4 months. Hopefully the new CEO will start addressing shareholders and the market soon.

21g/t mentioned @ 2:49

These are only exercisable after 3 years as well which provides 'golden handcuffs' - an incentive for the CEO and the other employees to stick with the job.

At least we have confirmation that the CEO has now joined.
Looking forward to some updates / shareholder communication in due course.

Landore's 1m ounces is very low grade - 1.0g/t. Probably economical at today's gold prices but not ideal.

I think the next step for CDX will be the tests on monkeys mentioned last year, as it appears they've been focusing on manufacturability.

Since when does 'pre-clinical development' mean clinical trials?
To be honest I thought pre-clinical development was what they'd been doing for the last 12-18 months, so was a bit surprised to read that.

Haven't seen any info on enrollments, but the trial did get moved from 'not started' to 'active' a few days ago which might indicate enrollment was progressing well:

https://discovery.dundee.ac.uk/en/projects/a-randomized-controlled-trial-of-sfx-01-to-improve-clinical-outco

Hopefully the new CEO will give us an update on this and the many other ongoing projects when he starts in the next week or two.

https://www.investegate.co.uk/open-orphan-plc--orph-/rns/option-to-acquire-chimagents-limited/202007150700090116T/

3 months from 15/7 so they have until 15/10 to take up the option.

"to acquire (the "Option") CHIMagents Limited ("CHIMagents") for a nominal sum."

Nominal sum - sounds like 0 shares will be issued?

Cheap warrants and placing shared galore sloshing around, and now an Ozzie using green screen to make it look like he's in the 'bush while talking crap.
I'm out.

https://www.irishtimes.com/business/health-pharma/irish-company-to-test-vaccines-on-volunteers-deliberately-infected-with-covid-19-1.4362506

Yes I meant ceiling..
I didn't see any information on the recipients of the loan notes in the RNS, so I assume they are PI clients of the brokers i.e. potentially out for a quick buck?

Prostophane does sound similar to the nutrional health application using naturally derived sulforaphane recently licenced to Juvanescence.
However this is not the same thing as Evgen's SFX-1 product which is the foundation of all the potential clinical applications of sulforaphane.